0.93

4.38% +0.039

Accelerate Diagnostics Inc (AXDX)

Panoramica Notizia Cronologia dei prezzi Financials Perché AXDX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$0.891

Aprire:

$0.88

Volume 24 ore:

3,503

Capitalizzazione di mercato:

$19.30M

Reddito:

$12.00M

Utile/perdita netta:

$-63.23M

Rapporto P/E:

-0.1182

EPS:

-7.87

Flusso di cassa netto:

$-43.02M

1 W Prestazione:

+3.33%

1M Prestazione:

+4.73%

6M Prestazione:

-82.68%

1 anno Prestazione:

+24.83%

Intervallo 1D:

$0.88

$0.93

Portata 52W:

$0.651

$8.72

Accelerate Diagnostics Inc Stock (AXDX) Company Profile

Nome

Accelerate Diagnostics Inc

Settore

Healthcare (1214)

Industria

Medical Devices (160)

Telefono

520 365 3100

Indirizzo

3950 South Country Club Road, Suite 470 4th Floor, Tucson, AZ

Dipendente

220

Cinguettio

@AXDXNews

Prossima data di guadagno

2024-05-08

Ultimi documenti SEC

AXDX's Discussions on Twitter

Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-03-09	Downgrade	Craig Hallum	Buy → Hold
2020-10-08	Iniziato	BTIG Research	Neutral
2020-08-07	Aggiornamento	Craig Hallum	Hold → Buy
2019-09-27	Downgrade	JP Morgan	Neutral → Underweight
2018-11-07	Downgrade	JP Morgan	Overweight → Neutral
2018-05-24	Iniziato	Craig Hallum	Hold
2017-12-13	Downgrade	BTIG Research	Buy → Neutral
2017-07-12	Ripresa	BTIG Research	Buy
2016-03-24	Iniziato	JP Morgan	Overweight
2015-12-16	Iniziato	Piper Jaffray	Overweight

Mostra tutto

Accelerate Diagnostics Inc Borsa (AXDX) Ultime notizie

Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Will Accelerate Diagnostics (AXDX) Report Negative Q1 Earnings? What You Should Know

Zacks Investment Research

Accuray (ARAY) Reports Q3 Loss, Lags Revenue Estimates

Zacks Investment Research

Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates

Zacks Investment Research

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Accelerate Diagnostics Inc Azioni (AXDX) Dati Finanziari

Accelerate Diagnostics Inc (AXDX) Reddito 2024

AXDX ha riportato un ricavo (TTM) di $12.00 milioni per il trimestre terminato il 2023-09-30, un -8.52% declino anno su anno.

Accelerate Diagnostics Inc (AXDX) Reddito netto 2024

AXDX l'utile netto (TTM) è stato di -$63.23 milioni per il trimestre terminato il 2023-09-30, un +10.55% aumento anno su anno.

Accelerate Diagnostics Inc (AXDX) Flusso di cassa 2024

AXDX ha registrato un flusso di cassa disponibile (TTM) di -$43.02 milioni per il trimestre conclusosi con 2023-09-30, un +17.22% aumento anno su anno.

Accelerate Diagnostics Inc (AXDX) Utile per azione 2024

L'utile per azione (TTM) di AXDX è stato pari a -$6.00 per il trimestre terminato il 2023-09-30, un +38.52% crescita anno su anno.

Accelerate Diagnostics Inc Azioni (AXDX) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Phillips Jack	Chief Executive Officer	Apr 17 '24	Sale	0.78	26,735	20,853	162,919
Phillips Jack	Chief Executive Officer	Apr 12 '24	Option Exercise	0.00	59,928	0	156,271
Phillips Jack	Chief Executive Officer	Apr 12 '24	Sale	0.86	26,545	22,829	129,726
Mertz Larry Michael	Chief Technology Officer	Apr 09 '24	Option Exercise	0.00	40,633	0	95,090
Patience David	Chief Financial Officer	Apr 09 '24	Option Exercise	0.00	37,468	0	63,715
Mertz Larry Michael	Chief Technology Officer	Apr 09 '24	Sale	0.87	13,984	12,166	81,106
Patience David	Chief Financial Officer	Apr 09 '24	Sale	0.87	13,296	11,568	50,419
Phillips Jack	Chief Executive Officer	Apr 04 '24	Option Exercise	0.00	35,523	0	112,230
Mertz Larry Michael	Chief Technology Officer	Apr 04 '24	Option Exercise	0.00	2,866	0	55,435
Phillips Jack	Chief Executive Officer	Apr 04 '24	Sale	0.88	15,887	13,981	96,343